Argentina vs Marshall Islands: Prevalence of anemia among women of reproductive age
Argentina
23.5%
in 2023
Marshall Islands
23.5%
in 2023
Argentina rank
113th
Marshall Islands rank
113th
Prevalence of anemia among women of reproductive age over time
- Argentina
- Marshall Islands
How they compare
Argentina currently reports 23.5% against 23.5% in Marshall Islands, a difference of 0.0%.
Across all 24 years both countries report, Marshall Islands has been ahead every year.
Argentina ranks 113th and Marshall Islands ranks 113th of 192 countries.
Marshall Islands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.6% | 22.7% | 2.1% | Marshall Islands |
| 2010s | 20.9% | 22.1% | 1.2% | Marshall Islands |
| 2020s | 22.7% | 22.9% | 0.2% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Argentina or Marshall Islands?
- Argentina, at 23.5% against 23.5% in Marshall Islands as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Argentina and Marshall Islands?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Marshall Islands?
- 24 years are reported by both, from 2000 to 2023.
- How do Argentina and Marshall Islands rank globally for prevalence of anemia among women of reproductive age?
- Argentina ranks 113th and Marshall Islands ranks 113th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.